Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.

NCT06802133 is registered in ClinicalTrials.gov with Collagen Matrix as lead sponsor.

NCT NCT06802133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06802133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring the Use of Collagen Dural Regeneration Matrix (DuraMatrix-Onlay Plus) in the Postmarket Phase.
Lead sponsor
Collagen Matrix
Phase
Observational
Overall status
Recruiting
Start date
January 13, 2025
Completion date
July 30, 2026
Enrollment
118 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

repair of dura mater